mercredi 13 avril 2016

Onco Actu du 13 avril 2016

1.1 Biologie - Gènes

Mystery of the 13 people with 'superhero DNA' [NHS Choices]

3.1 Tabac

We need a strategy to help people with mental health problems quit smoking [The Guardian]

Largest Study Yet Shows Mother’s Smoking Changes Baby’s Epigenome [NIH Directors's Blog]

4.1 Dép., diag. & prono. - Prostate

Martin Roland: Who should have PSA testing for prostate cancer? [BMJ Blogs]

4.12 Biopsies liquides

New supersensitive biosensor for early cancer detection [PHG Foundation]

5. Traitements

Ovarian cancer and the case of elusive cure [Pharmafile]

5.10 Traitements - Essais

Head-to-head study demonstrating Giotrif® (afatinib) significantly improved clinical outcomes compared to Iressa® (gefitinib) in EGFR mutation-positive advanced non-small cell lung cancer published in The Lancet Oncology [Boehringer Ingelheim]

Editorial: Making the Most of Clinical Trial Data [NY Times]

5.12 Immunothérapies

Sean Parker Just Gave $250M to the Darling of Cancer Research [WIRED]

Sean Parker’s $250 Million Bet on Hacking the Immune System to Beat Cancer [MIT Technology Review]

Sean Parker sets up $250 million cancer immunotherapy collaboration [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

Medivation Said to Have Rebuffed Sanofi Takeover Approach [Bloomberg]

5.2.3 Pharma - économie

Drug industry lashes out at Massachusetts drug price transparency effort [FiercePharma]

5.3.4 Traitements - AMM (FDA, EMA)

Clovis Lung Cancer Drug Trashed at FDA Panel, CEO Exit Next? [TheStreet]

Clovis Oncology Provides Update on FDA Oncologic Drugs Advisory Committee Meeting to Review Rociletinib for Treatment of Advanced T790M-Positive Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer [Clovis Oncology]

FDA panel votes against quick approval for Clovis cancer drug [Reuters]

5.4 Traitements - Economie

New myeloma meds work better than the old, but they're far too expensive: Report [FiercePharma]

6. Lutte contre les cancers

Doctors Often Overestimate Promise of New Drugs [WebMD]

6.1 Observation

Cancer survival rates higher at academic medical centers, study says [Miami Herald]

Obesity 'likely culprit' behind womb cancer rise [BBC News]

Obesity epidemic is fuelling rise in womb cancer, charity warns [The Guardian]

6.10 Politiques

Q&A: Tech expert and cancer survivor to lead U.S. 1-million-person health study [Science]

6.11 Patients

At A Conference On Cancer, Patients Take Notes Like Their Lives Depend On It [Forbes]

6.6 Publications

Cancer researcher earns 3 more retractions following NIH misconduct investigation [Retraction Watch]

On Moose and Medians (Or Why We Are Stuck With The Impact Factor) [The Schorlarly Kitchen]

6.7 DMP, Big Data & applis

IBM and American Cancer Society to Create Virtual Cancer Advisor [Fortune]

Society and IBM Collaborate to Create Virtual Cancer Health Advisor [ACS]